Stockreport

Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF   CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its third quarter 2024 financial results on T [Read more]